Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.
Q3 2026 earnings beat with raised guidance and a strengthened post-offering balance sheet support a positive near-term bias, though ongoing unprofitability caps upside.
Teknova reported Q3 2026 revenue of $12.7M, up 22% YoY and ahead of the ~$11.7M consensus, with EPS of -$0.06 beating the -$0.07 estimate. The company raised FY2026 revenue guidance to $46-48M and reaffirmed Free Cash Outflow under $8M, a positive near-term signal likely to sustain buying interest.
Alpha Teknova Press Release (GlobeNewswire)Teknova closed an underwritten offering of 9.2M shares at $5.00 for ~$42.9M net proceeds, boosting balance sheet flexibility and adding new institutional investors. While dilution is a consideration, the completed raise removes near-term financing overhang and supports execution.
SEC Filing (8-K)Management indicated the company remains unprofitable with a $3.5M Q3 net loss and that adjusted EBITDA positivity is not expected until annualized revenue reaches $52-57M, above current guidance. This tempers enthusiasm and may cap near-term upside.
Yahoo FinanceTeknova launched the Fill-Tek Dispensing System, adding flexibility for custom single-use bag sizes and fill volumes across RUO, RUO+, and GMP grades. The product expansion supports the growth narrative but is unlikely to be a major standalone near-term price driver.
Alpha Teknova Press Release (GlobeNewswire)